Von dem Buch The Politics of Pharmaceutical Policy Reform: A Study of Generic Drug Regulation in Brazil (SpringerBriefs in Political Science) haben wir 2 gleiche oder sehr ähnliche Ausgaben identifiziert!
Falls Sie nur an einem bestimmten Exempar interessiert sind, können Sie aus der folgenden Liste jenes wählen, an dem Sie interessiert sind:
100%: Elize Massard da Fonseca: The Politics of Pharmaceutical Policy Reform: A Study of Generic Drug Regulation in Brazil (SpringerBriefs in Political Science) (ISBN: 9783319125657) 2014, 2015. Ausgabe, in Englisch, auch als eBook.Nur diese Ausgabe anzeigen…
100%: Massard da Fonseca, Elize: The Politics of Pharmaceutical Policy Reform: A Study of Generic Drug Regulation in Brazil (SpringerBriefs in Political Science) (ISBN: 9783319125640) in Deutsch, Taschenbuch.Nur diese Ausgabe anzeigen…
The Politics of Pharmaceutical Policy Reform: A Study of Generic Drug Regulation in Brazil (SpringerBriefs in Political Science)
14 Angebote vergleichen
| Preise | 2016 | 2018 | 2019 |
|---|---|---|---|
| Schnitt | € 51,16 | € 25,58 | € 38,82 |
| Nachfrage |
1
The Politics of Pharmaceutical Policy Reform - A Study of Generic Drug Regulation in Brazil
DE NW EB DLISBN: 9783319125657 bzw. 3319125656, in Deutsch, Springer International Publishing, neu, E-Book, elektronischer Download.
Lieferung aus: Deutschland, Versandkostenfrei.
The Politics of Pharmaceutical Policy Reform: Brazil is renowned worldwide for its remarkable reforms in pharmaceutical regulation, which have enhanced access to essential medicines while lowering drug costs. This book innovates by analysing the generic drug? reform in Brazil, demonstrating that pharmaceutical regulation is only partially influenced by non-state actors. Little is known about the institutional antecedents and policy process that channeled this regulatory reform. This is particularly intriguing because a regulatory shift in the pharmaceutical sector requires the participation of a number of stakeholders and interest groups in the policy process. Fonseca examines the generic drug reform`s causes and consequences. No study has approached the generic drug regulation in Brazil from this perspective. Englisch, Ebook.
The Politics of Pharmaceutical Policy Reform: Brazil is renowned worldwide for its remarkable reforms in pharmaceutical regulation, which have enhanced access to essential medicines while lowering drug costs. This book innovates by analysing the generic drug? reform in Brazil, demonstrating that pharmaceutical regulation is only partially influenced by non-state actors. Little is known about the institutional antecedents and policy process that channeled this regulatory reform. This is particularly intriguing because a regulatory shift in the pharmaceutical sector requires the participation of a number of stakeholders and interest groups in the policy process. Fonseca examines the generic drug reform`s causes and consequences. No study has approached the generic drug regulation in Brazil from this perspective. Englisch, Ebook.
2
The Politics of Pharmaceutical Policy Reform
~EN NW EB DLISBN: 9783319125657 bzw. 3319125656, vermutlich in Englisch, Springer Shop, neu, E-Book, elektronischer Download.
Lieferung aus: Vereinigte Staaten von Amerika, Lagernd, zzgl. Versandkosten.
Brazil is renowned worldwide for its remarkable reforms in pharmaceutical regulation, which have enhanced access to essential medicines while lowering drug costs. This book innovates by analysing the generic drug reform in Brazil, demonstrating that pharmaceutical regulation is only partially influenced by non-state actors. Little is known about the institutional antecedents and policy process that channeled this regulatory reform. This is particularly intriguing because a regulatory shift in the pharmaceutical sector requires the participation of a number of stakeholders and interest groups in the policy process. Fonseca examines the generic drug reform’s causes and consequences. No study has approached the generic drug regulation in Brazil from this perspective. The Politics of Pharmaceutical Policy Reform: A Study of Generic Drug Regulation in Brazil, explores the following: · The politics of pharmaceutical regulation in Brazil over the last 25 years. · The political negotiations to approve the Generic Drug Act, which involved a hard-to-reach agreement between the pharmaceutical industry (national and multinational), the Ministry of Health, and Congress · The controversial decisions to regulate packaging and pharmaceutical equivalence. · The surprising success of Brazilian pharmaceutical firms, which became market champions in a sector largely dominated by multinational firms. · Comparative lessons from the Brazilian case for the political construction of regulatory standards to regulate generic drugs and its effects on global health. This book will interest political scientists and health policy scholars concerned with the political conflicts in the pharmaceutical sector. It argues against well-established approaches to regulatory capture such as control of the regulatory process by interest groups and policy diffusion. It can be used as evidence for graduate courses in public policy, health policy and political science. Because Brazil is one of the largest markets for pharmaceuticals in the world, business leaders and consultancy firms would also be interested. eBook.
Brazil is renowned worldwide for its remarkable reforms in pharmaceutical regulation, which have enhanced access to essential medicines while lowering drug costs. This book innovates by analysing the generic drug reform in Brazil, demonstrating that pharmaceutical regulation is only partially influenced by non-state actors. Little is known about the institutional antecedents and policy process that channeled this regulatory reform. This is particularly intriguing because a regulatory shift in the pharmaceutical sector requires the participation of a number of stakeholders and interest groups in the policy process. Fonseca examines the generic drug reform’s causes and consequences. No study has approached the generic drug regulation in Brazil from this perspective. The Politics of Pharmaceutical Policy Reform: A Study of Generic Drug Regulation in Brazil, explores the following: · The politics of pharmaceutical regulation in Brazil over the last 25 years. · The political negotiations to approve the Generic Drug Act, which involved a hard-to-reach agreement between the pharmaceutical industry (national and multinational), the Ministry of Health, and Congress · The controversial decisions to regulate packaging and pharmaceutical equivalence. · The surprising success of Brazilian pharmaceutical firms, which became market champions in a sector largely dominated by multinational firms. · Comparative lessons from the Brazilian case for the political construction of regulatory standards to regulate generic drugs and its effects on global health. This book will interest political scientists and health policy scholars concerned with the political conflicts in the pharmaceutical sector. It argues against well-established approaches to regulatory capture such as control of the regulatory process by interest groups and policy diffusion. It can be used as evidence for graduate courses in public policy, health policy and political science. Because Brazil is one of the largest markets for pharmaceuticals in the world, business leaders and consultancy firms would also be interested. eBook.
3
The Politics of Pharmaceutical Policy Reform - A Study of Generic Drug Regulation in Brazil
DE NWISBN: 9783319125657 bzw. 3319125656, in Deutsch, Springer International Publishing, neu.
Lieferung aus: Deutschland, Versandkostenfrei.
The Politics of Pharmaceutical Policy Reform: Brazil is renowned worldwide for its remarkable reforms in pharmaceutical regulation, which have enhanced access to essential medicines while lowering drug costs. This book innovates by analysing the generic drug reform in Brazil, demonstrating that pharmaceutical regulation is only partially influenced by non-state actors. Little is known about the institutional antecedents and policy process that channeled this regulatory reform. This is particularly intriguing because a regulatory shift in the pharmaceutical sector requires the participation of a number of stakeholders and interest groups in the policy process. Fonseca examines the generic drug reform`s causes and consequences. No study has approached the generic drug regulation in Brazil from this perspective. Englisch, Ebook.
The Politics of Pharmaceutical Policy Reform: Brazil is renowned worldwide for its remarkable reforms in pharmaceutical regulation, which have enhanced access to essential medicines while lowering drug costs. This book innovates by analysing the generic drug reform in Brazil, demonstrating that pharmaceutical regulation is only partially influenced by non-state actors. Little is known about the institutional antecedents and policy process that channeled this regulatory reform. This is particularly intriguing because a regulatory shift in the pharmaceutical sector requires the participation of a number of stakeholders and interest groups in the policy process. Fonseca examines the generic drug reform`s causes and consequences. No study has approached the generic drug regulation in Brazil from this perspective. Englisch, Ebook.
4
The Politics of Pharmaceutical Policy Reform: A Study of Generic Drug Regulation in Brazil (SpringerBriefs in Political Science) (2014)
EN NW EB DLISBN: 9783319125657 bzw. 3319125656, in Englisch, 117 Seiten, 2015. Ausgabe, Springer, neu, E-Book, elektronischer Download.
Lieferung aus: Deutschland, E-Book zum Download, Versandkostenfrei.
Brazil is renowned worldwide for its remarkable reforms in pharmaceutical regulation, which have enhanced access to essential medicines while lowering drug costs. This book innovates by analysing the generic drug reform in Brazil, demonstrating that pharmaceutical regulation is only partially influenced by non-state actors. Little is known about the institutional antecedents and policy process that channeled this regulatory reform. This is particularly intriguing because a regulatory shift in the pharmaceutical sector requires the participation of a number of stakeholders and interest groups in the policy process. Fonseca examines the generic drug reform’s causes and consequences. No study has approached the generic drug regulation in Brazil from this perspective. The Politics of Pharmaceutical Policy Reform: A Study of Generic Drug Regulation in Brazil, explores the following: · The politics of pharmaceutical regulation in Brazil over the last 25 years.· The political negotiations to approve the Generic Drug Act, which involved a hard-to-reach agreement between the pharmaceutical industry (national and multinational), the Ministry of Health, and Congress· The controversial decisions to regulate packaging and pharmaceutical equivalence.· The surprising success of Brazilian pharmaceutical firms, which became market champions in a sector largely dominated by multinational firms.· Comparative lessons from the Brazilian case for the political construction of regulatory standards to regulate generic drugs and its effects on global health. This book will interest political scientists and health policy scholars concerned with the political conflicts in the pharmaceutical sector. It argues against well-established approaches to regulatory capture such as control of the regulatory process by interest groups and policy diffusion. It can be used as evidence for graduate courses in public policy, health policy and political science. Because Brazil is one of the largest markets for pharmaceuticals in the world, business leaders and consultancy firms would also be interested. , Kindle Edition, Ausgabe: 2015, Format: Kindle eBook, Label: Springer, Springer, Produktgruppe: eBooks, Publiziert: 2014-11-17, Freigegeben: 2014-11-17, Studio: Springer.
Brazil is renowned worldwide for its remarkable reforms in pharmaceutical regulation, which have enhanced access to essential medicines while lowering drug costs. This book innovates by analysing the generic drug reform in Brazil, demonstrating that pharmaceutical regulation is only partially influenced by non-state actors. Little is known about the institutional antecedents and policy process that channeled this regulatory reform. This is particularly intriguing because a regulatory shift in the pharmaceutical sector requires the participation of a number of stakeholders and interest groups in the policy process. Fonseca examines the generic drug reform’s causes and consequences. No study has approached the generic drug regulation in Brazil from this perspective. The Politics of Pharmaceutical Policy Reform: A Study of Generic Drug Regulation in Brazil, explores the following: · The politics of pharmaceutical regulation in Brazil over the last 25 years.· The political negotiations to approve the Generic Drug Act, which involved a hard-to-reach agreement between the pharmaceutical industry (national and multinational), the Ministry of Health, and Congress· The controversial decisions to regulate packaging and pharmaceutical equivalence.· The surprising success of Brazilian pharmaceutical firms, which became market champions in a sector largely dominated by multinational firms.· Comparative lessons from the Brazilian case for the political construction of regulatory standards to regulate generic drugs and its effects on global health. This book will interest political scientists and health policy scholars concerned with the political conflicts in the pharmaceutical sector. It argues against well-established approaches to regulatory capture such as control of the regulatory process by interest groups and policy diffusion. It can be used as evidence for graduate courses in public policy, health policy and political science. Because Brazil is one of the largest markets for pharmaceuticals in the world, business leaders and consultancy firms would also be interested. , Kindle Edition, Ausgabe: 2015, Format: Kindle eBook, Label: Springer, Springer, Produktgruppe: eBooks, Publiziert: 2014-11-17, Freigegeben: 2014-11-17, Studio: Springer.
5
The Politics of Pharmaceutical Policy Reform (2014)
EN NW EB DLISBN: 9783319125657 bzw. 3319125656, in Englisch, Springer, Springer, Springer, neu, E-Book, elektronischer Download.
Lieferung aus: Vereinigtes Königreich Großbritannien und Nordirland, in-stock.
Brazil is renowned worldwide for its remarkable reforms in pharmaceutical regulation, which have enhanced access to essential medicines while lowering drug costs. This book innovates by analysing the generic drug reform in Brazil, demonstrating t.
Brazil is renowned worldwide for its remarkable reforms in pharmaceutical regulation, which have enhanced access to essential medicines while lowering drug costs. This book innovates by analysing the generic drug reform in Brazil, demonstrating t.
6
Symbolbild
The Politics of Pharmaceutical Policy Reform. A Study of Generic Drug Regulation in Brazil (2014)
DE PB NWISBN: 9783319125640 bzw. 3319125648, in Deutsch, Springer, Taschenbuch, neu.
Von Händler/Antiquariat, Herb Tandree Philosophy Books [17426], Stroud, GLOS, United Kingdom.
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
8
The Politics of Pharmaceutical Policy Reform
DE NWISBN: 9783319125640 bzw. 3319125648, in Deutsch, neu.
Lieferung aus: Deutschland, 2-3 Werktage.
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
9
The Politics of Pharmaceutical Policy Reform - A Study of Generic Drug Regulation in Brazil
DE PB NWISBN: 9783319125640 bzw. 3319125648, in Deutsch, Springer-Verlag Gmbh, Taschenbuch, neu.
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
10
Symbolbild
The Politics of Pharmaceutical Policy Reform (2015)
DE PB NWISBN: 9783319125640 bzw. 3319125648, in Deutsch, Springer-Verlag Gmbh Jan 2015, Taschenbuch, neu.
Lieferung aus: Deutschland, Versandkostenfrei.
Von Händler/Antiquariat, AHA-BUCH GmbH [51283250], Einbeck, Germany.
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
Von Händler/Antiquariat, AHA-BUCH GmbH [51283250], Einbeck, Germany.
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
Lade…